C. R. Bard

Free public records show C. R. Bard in 2 of the markets we cover. It is not a key player in our research.

[1] ClinicalTrials.gov, Studies led by C. R. Bard or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.

Public data

Free public data on C. R. Bard

From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.

About our sources

Company facts

Website
crbard.com
Home country
United States
Stock listing
NYSE: BCR
Legal name
C. R. Bard, Inc.

Source: Wikidata, Company record Q5006774. Retrieved 13 Nov 2026.

Source: GLEIF, Legal entity record, LEI 549300XS4HD3R8MDYK78. Retrieved 13 Nov 2026.

US device clearances

94 510(k) clearances and PMA approvals since 2015

Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Retrieved 13 Nov 2026.

See them on openFDA (opens in a new tab)

Trials over time

Studies C. R. Bard leads, by the year they started and their phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • No phase (devices, observational)

Source: ClinicalTrials.gov, Studies with C. R. Bard or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.

Markets where public records show them

Markets we cover where free public records show C. R. Bard: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.

Topics

The topics of the markets C. R. Bard is in.

All topics

Search all reports for C. R. Bard All companies